|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
159,210,000 |
Market
Cap: |
1.10(B) |
Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,459 |
52
Week Range: |
$2.7 - $7.11 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Chu May |
Senior VP - Quality Affairs |
|
2004-12-02 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
83,027 |
|
- |
|
Chu May |
Senior VP - Quality Affairs |
|
2004-12-02 |
4 |
B |
$10.94 |
$2,002 |
D/D |
183 |
55,288 |
2.66 |
- |
|
Hsu Larry |
President |
|
2004-12-02 |
4 |
B |
$10.94 |
$2,002 |
D/D |
183 |
2,383,771 |
2.73 |
- |
|
Hsiao Charles |
Director |
|
2004-12-02 |
4 |
B |
$0.00 |
$0 |
I/I |
3,531,605 |
3,531,605 |
2.02 |
- |
|
Hsiao Charles |
Director |
|
2004-12-02 |
4 |
B |
$10.94 |
$2,002 |
D/D |
183 |
3,471 |
2.31 |
- |
|
Chu May |
Senior VP - Quality Affairs |
|
2004-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
83,027 |
|
- |
|
Chu May |
Senior VP - Quality Affairs |
|
2004-09-09 |
4 |
S |
$16.80 |
$105,134 |
D/D |
(6,258) |
55,105 |
|
- |
|
Chu May |
Senior VP Quality Affairs |
|
2004-09-01 |
4 |
B |
$12.58 |
$2,000 |
D/D |
159 |
61,363 |
2.66 |
- |
|
Hsu Larry |
President |
|
2004-09-01 |
4 |
B |
$12.58 |
$2,000 |
D/D |
159 |
2,050,275 |
2.73 |
- |
|
Hsiao Charles |
Director |
|
2004-09-01 |
4 |
B |
$12.58 |
$2,000 |
D/D |
159 |
3,288 |
2.31 |
- |
|
Hsiao Charles |
Director |
|
2004-08-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,347,419 |
3,531,605 |
|
- |
|
Hsiao Charles |
Director |
|
2004-08-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,347,419 |
3,129 |
|
- |
|
Chu May |
Senior Vice President - QA |
|
2004-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
83,027 |
|
- |
|
Chu May |
Senior Vice President - QA |
|
2004-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
0 |
61,204 |
|
- |
|
Chu May |
Senior VP - Quality Affairs |
|
2004-06-10 |
4 |
S |
$20.50 |
$76,794 |
D/D |
(3,742) |
61,204 |
|
- |
|
Burr Robert L |
Director |
|
2004-06-08 |
4 |
S |
$21.25 |
$212,500 |
D/D |
(10,000) |
29,150 |
|
- |
|
Burr Robert L |
Director |
|
2004-06-08 |
4 |
S |
$21.25 |
$289,000 |
D/D |
(13,600) |
6,057 |
|
- |
|
Markbreiter Michael |
Director |
|
2004-06-07 |
4/A |
S |
$21.70 |
$396,332 |
D/D |
(18,100) |
0 |
|
- |
|
Markbreiter Michael |
Director |
|
2004-06-07 |
4/A |
S |
$21.81 |
$41,439 |
D/D |
(1,900) |
11,300 |
|
- |
|
Hsiao Charles |
Director |
|
2004-06-07 |
4 |
S |
$21.08 |
$12,684,500 |
D/D |
(600,000) |
0 |
|
- |
|
Edwards Barry R |
CEO |
|
2004-06-07 |
4 |
S |
$21.82 |
$2,618,436 |
D/D |
(120,000) |
1,901 |
|
- |
|
Hsu Larry |
President |
|
2004-06-07 |
4 |
S |
$21.08 |
$12,684,500 |
D/D |
(600,000) |
2,050,009 |
|
- |
|
Markbreiter Michael |
Director |
|
2004-06-07 |
4 |
S |
$21.70 |
$437,771 |
D/D |
(20,000) |
0 |
|
- |
|
Doll David S |
Senior VP - Sales & Marketing |
|
2004-06-07 |
4 |
S |
$21.08 |
$645,520 |
D/D |
(30,000) |
2,279 |
|
- |
|
Spiegler Cornel C |
Chief Financial Officer |
|
2004-06-07 |
4 |
S |
$21.77 |
$1,221,850 |
D/D |
(56,000) |
10,750 |
|
- |
|
531 Records found
|
|
Page 20 of 22 |
|
|